Thursday, July 6, 2017

Oncogene - Table of Contents alert Volume 36 Issue 27

If you are unable to see the message below, click here to view.

Frontiers in Cancer Science 2017 
FCS 2017, jointly organised by 7 major institutes in Singapore, features an impressive line-up of speakers from across the globe. It converges the latest cancer discoveries around the world and promises ground-breaking and innovative insights into cancer research. Register now to secure your chance to learn from the experts!


Volume 36, Issue 27 (July 2017)

In this issue
Original Articles
Short Communication

Also new
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Celebrating 30 years of Oncogene — 1987 to 2017

Thank you to the editors, board members, contributors, reviewers and readers, past and present for their invaluable contributions, and for bringing the journal to this milestone. 

Watch our anniversary video showing a brief impact overview >>>

Original Articles


Phosphorylation-mediated activation of LDHA promotes cancer cell invasion and tumour metastasis

L Jin, J Chun, C Pan, G N Alesi, D Li, K R Magliocca, Y Kang, Z G Chen, D M Shin, F R Khuri, J Fan and S Kang

Oncogene 2017 36: 3797-3806; advance online publication, February 20, 2017; 10.1038/onc.2017.6

Abstract | Full Text

EGFR-mediated macrophage activation promotes colitis-associated tumorigenesis

D M Hardbower, L A Coburn, M Asim, K Singh, J C Sierra, D P Barry, A P Gobert, M B Piazuelo, M K Washington and K T Wilson

Oncogene 2017 36: 3807-3819; advance online publication, March 6, 2017; 10.1038/onc.2017.23

Abstract | Full Text

NLRP1 promotes tumor growth by enhancing inflammasome activation and suppressing apoptosis in metastatic melanoma

Z Zhai, W Liu, M Kaur, Y Luo, J Domenico, J M Samson, Y G Shellman, D A Norris, C A Dinarello, R A Spritz and M Fujita

Oncogene 2017 36: 3820-3830; advance online publication, March 6, 2017; 10.1038/onc.2017.26

Abstract | Full Text

An FGFR inhibitor converts the tumor promoting effect of TGF-β by the induction of fibroblast-associated genes of hepatoma cells

H-R Zhang, X-D Wang, X Yang, D Chen, J Hao, R Cao and X-Z Wu

Oncogene 2017 36: 3831-3841; advance online publication, March 6, 2017; 10.1038/onc.2016.512

Abstract | Full Text

Activated MEK cooperates with Cdkn2a and Pten loss to promote the development and maintenance of melanoma OPEN

H Yang, D A Kircher, K H Kim, A H Grossmann, M W VanBrocklin, S L Holmen and J P Robinson

Oncogene 2017 36: 3842-3851; advance online publication, March 6, 2017; 10.1038/onc.2016.526

Abstract | Full Text

The pre-rRNA processing factor DEF is rate limiting for the pathogenesis of MYCN-driven neuroblastoma OPEN

T Tao, S B Sondalle, H Shi, S Zhu, A R Perez-Atayde, J Peng, S J Baserga and A T Look

Oncogene 2017 36: 3852-3867; advance online publication, March 6, 2017; 10.1038/onc.2016.527

Abstract | Full Text

Histone demethylase JMJD1A promotes urinary bladder cancer progression by enhancing glycolysis through coactivation of hypoxia inducible factor 1α

W Wan, K Peng, M Li, L Qin, Z Tong, J Yan, B Shen and C Yu

Oncogene 2017 36: 3868-3877; advance online publication, March 6, 2017; 10.1038/onc.2017.13

Abstract | Full Text

LncRNA MEG3 downregulation mediated by DNMT3b contributes to nickel malignant transformation of human bronchial epithelial cells via modulating PHLPP1 transcription and HIF-1α translation

C Zhou, C Huang, J Wang, H Huang, J Li, Q Xie, Y Liu, J Zhu, Y Li, D Zhang, Q Zhu and C Huang

Oncogene 2017 36: 3878-3889; advance online publication, March 6, 2017; 10.1038/onc.2017.14

Abstract | Full Text

Piccolo mediates EGFR signaling and acts as a prognostic biomarker in esophageal squamous cell carcinoma

W Zhang, R Hong, L Xue, Y Ou, X Liu, Z Zhao, W Xiao, D Dong, L Dong, M Fu, L Ma, N Lu, H Chen, Y Song and Q Zhan

Oncogene 2017 36: 3890-3902; advance online publication, March 6, 2017; 10.1038/onc.2017.15

Abstract | Full Text

SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis

L Yu, Y Di, L Xin, Y Ren, X Liu, X Sun, W Zhang, Z Yao and J Yang

Oncogene 2017 36: 3903-3914; advance online publication, March 6, 2017; 10.1038/onc.2017.30

Abstract | Full Text

Cytosolic malate dehydrogenase activity helps support glycolysis in actively proliferating cells and cancer

E A Hanse, C Ruan, M Kachman, D Wang, X H Lowman and A Kelekar

Oncogene 2017 36: 3915-3924; advance online publication, March 6, 2017; 10.1038/onc.2017.36

Abstract | Full Text

XRN2 promotes EMT and metastasis through regulating maturation of miR-10a

H Zhang, Y Lu, E Chen, X Li, B Lv, H G Vikis and P Liu

Oncogene 2017 36: 3925-3933; advance online publication, March 20, 2017; 10.1038/onc.2017.39

Abstract | Full Text

Short Communication


Isoprenylcysteine carboxylmethyltransferase is critical for malignant transformation and tumor maintenance by all RAS isoforms OPEN

H Y Lau, J Tang, P J Casey and M Wang

Oncogene 2017 36: 3934-3942; advance online publication, February 13, 2017; 10.1038/onc.2016.508

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2017 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: